Nicotine Replacement Therapy Market Is Anticipated To Grow With Steady CAGR By 2027: Acumen Research And Consulting
February 09, 2021 13:57 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently forthcoming report titled “Global Nicotine Replacement Therapy Market – Global Industry Analysis, Market...
Nicotine Replacement Therapy Market to Exhibit 4.2% CAGR by 2027 Backed by Increasing Government Initiatives to Promote Anti-Smoking Activities, reports Fortune Business Insights™
September 21, 2020 07:32 ET
|
Fortune Business Insights
Pune, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The global nicotine replacement therapy market is expected to gain momentum by exhibiting a CAGR of 4.2% between 2020 and 2027. This is attributable to...
Nicotine Replacement Therapy Market worth USD 3.54 billion by 2027; Increasing Cases of Smoking Cessation in North America to Stoke Exponential Demand
August 04, 2020 12:09 ET
|
Fortune Business Insights
Pune, Aug. 04, 2020 (GLOBE NEWSWIRE) -- The global nicotine replacement therapy market is expected to gain momentum by exhibiting a CAGR of 4.2% between 2020 and 2027. This is attributable...
NetworkNewsWire Announces Publication on Alternatives to Nicotine Delivery
January 10, 2018 08:30 ET
|
NetworkNewsWire
NEW YORK, Jan. 10, 2018 (GLOBE NEWSWIRE) -- via NetworkNewsWire — NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial...
London Drugs and QuitNow Offering 10 Dedicated Smoking Cessation Clinics in the Lower Mainland in October
October 02, 2017 10:00 ET
|
London Drugs Ltd.
VANCOUVER, British Columbia, Oct. 02, 2017 (GLOBE NEWSWIRE) -- During the month of October, tobacco users in the lower mainland will have a new support resource to help them kick their habit and...
CN Creative Advances Regulatory Initiatives for Its Nicadex(TM) and Intellicig(R) Harm Reduction/Smoking Cessation Products
May 30, 2012 05:30 ET
|
CN Creative Ltd.
UK Manufacturing Facility Receives "Pharmaceutical Grade" cGMP Designation
Plans for Clinical Trial of Nicadex Electronic Inhaler Nicotine Replacement Therapy On Track
Will Leverage MHRA...
CN Creative Appoints Chief Financial Officer
April 04, 2012 05:00 ET
|
CN Creative Ltd.
MANCHESTER, England, April 4, 2012 (GLOBE NEWSWIRE) -- CN Creative, Ltd. (CNC), a healthcare company providing innovative and sustainable solutions to reduce smoking and smoking-related illnesses,...